BlackRock Fund Advisors - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$61,000
+24.5%
58,345
+28.6%
0.00%
Q3 2016$49,000
+444.4%
45,385
+272.5%
0.00%
Q2 2016$9,000
-99.6%
12,184
-99.4%
0.00%
-100.0%
Q1 2016$2,299,000
-54.1%
1,964,900
-3.8%
0.00%0.0%
Q4 2015$5,004,000
-14.8%
2,042,501
+4.3%
0.00%
-50.0%
Q3 2015$5,875,000
-28.0%
1,958,285
-0.9%
0.00%0.0%
Q2 2015$8,165,000
+920.6%
1,976,992
+970.0%
0.00%
Q1 2015$800,000
+42.9%
184,773
-2.0%
0.00%
Q4 2014$560,000
-3.9%
188,458
+7.3%
0.00%
Q3 2014$583,000
+45.0%
175,660
+10.6%
0.00%
Q2 2014$402,000158,8560.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders